Clinical trial: A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA（QT-019C） in Patients With Relapsed / Refractory Neurological Autoimmune Diseases

https://clinicaltrials.gov/study/NCT07392528?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18705

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the
Safety and Efficacy of Melatonin Administration in Patients With Multiple
Progressive Primary Sclerosis (MELATOMS)

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-508457-10-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18707

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients

https://clinicaltrials.gov/study/NCT07392879?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18706

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07388992?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18701

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Phase 1, Open-label, Multiple Ascending Dose Basket Study to Evaluate the Safety and Activity of DR-0201 in Patients With Select Autoimmune Rheumatic Diseases

https://clinicaltrials.gov/study/NCT06647069?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18702

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A Pilot Study of Ublituximab in People With MS Experiencing Wearing Off Phenomena While Receiving Treatment With Ocrelizumab

https://clinicaltrials.gov/study/NCT07389590?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18703

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial

https://clinicaltrials.gov/study/NCT07390201?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_18704

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

https://gregory-ms.com/articles/311614/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_311614

Neurotmesis remains a significant clinical challenge due to limited intrinsic regenerative capacity and suboptimal outcomes of current therapies. Mesenchymal stromal cells (MSCs) secretome has emerged as a promising cell-free alternative. This study aimed to evaluate the regenerative efficacy of primed MSC secretome in a rat model of sciatic nerve neurotmesis. Secretome priming enhanced the sec...

#MultipleSclerosis #MSchat #MS #Neurology

https://gregory-ms.com/articles/311631/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_311631

The retinoid X receptor agonist bexarotene promotes remyelination in patients with multiple sclerosis. Murine studies have also shown that RXR agonists have anti-inflammatory effects.

#MultipleSclerosis #MSchat #MS #Neurology

I might try adaptive skiing next time (seated skiing). There’s a school that specialises in that in Zell and apparently #MultipleSclerosis is one of the conditions they see quite often. I love the mountains, and this might help prolong my enjoyment of them in winter.

#FuckMS #MS